This site complies with the HONcode standard for trustworthy health information:
verify here.

Rewarding for
you and us
Defeat Diabetes Foundation

Defeat Diabetes
Foundation
150 153rd Ave,
Suite 300
Madeira Beach, FL 33708

Drugs » Self-Management

Search our News Articles Archives for diabetes and health news. Search by word or phrase. The latest article will appear first.

New Magic Weight-Loss Pill rimonabant (Acomplia) Offers Modest Results, Blocks 'Munchies'

Posted: Wednesday, October 25, 2006

A new drug billed as a magic bullet for obesity — rimonabant (Acomplia) — does help people lose weight, although not that much weight, and also helps lower cardiac risk factors, according to a review of studies.

Diabetes Drugs Could Stop Deadly Sepsis

Posted: Thursday, October 19, 2006

A new class of diabetes drugs appears to hold promise against sepsis, a severe and often fatal reaction of the immune system to infection.

No Clear Evidence for Ultra-Low Cholesterol Targets

Posted: Thursday, October 12, 2006

There is no scientifically valid evidence to support the ultra-low LDL target of 70 milligrams/deciliter for very high-risk patients. Further, they suggest that the evidence previously cited to support an LDL goal of less than 100mg/dL for high risk patients also has major flaws.

Exenatide As Effective As Insulin

Posted: Thursday, October 12, 2006

Patients on exenatide lost weight, while insulin patients gained weight.

Antihypertensives Cut New-Onset Diabetes by a Third

Posted: Thursday, October 12, 2006

A new analysis of the ASCOT study shows the clearest proof so far that antihypertensive treatment with an ACE inhibitor and calcium channel blocker limits new-onset diabetes, while treatment with a ß-blocker (atenolol), and thiazide diuretic (bendroflumethiazide) helps cause it.

Role of Blood Glucose Self-Monitoring in Medicare Patients with Type 2 Diabetes

Posted: Thursday, October 12, 2006

The Centers for Medicare and Medicaid Services is questioning whether or not Patients with Type 2 Diabetes benefit from self-monitoring of their blood glucose and should they pay for monitor and strips.

New Diabetes Drug Galvus Matches Avandia in Control of Blood Sugars

Posted: Thursday, October 12, 2006

The new diabetes drug from Novartis, Galvus cuts blood sugar levels as much as GlaxoSmithKlines established medicine Avandia and without the side effects.

New Joint Guidelines for CVD and Diabetes from 2 European Associations

Posted: Thursday, October 12, 2006

Diabetes and cardiovascular diseases (CVD) often appear as the two sides of a coin: on one side, diabetes has been rated as an equivalent of coronary heart disease, and conversely, many patients with established coronary heart disease (65-70 %) suffer from diabetes or its pre-states.

Are Your Diabetic Patients Part of the 21% Who do Not Take Their Meds?

Posted: Thursday, October 12, 2006

About 21 percent of individuals with diabetes do not regularly take their blood-sugar lowering, blood-pressure lowering or cholesterol-lowering pills, researchers found in study of 11,532 diabetes patients.

New DPP-4 and Glitazone Diabetes Drugs Will Account for 72% of the Diabetes Mark

Posted: Thursday, October 05, 2006

According to a new report from Decision Resources, the New Novel Drug Classes Will Account for 76% of the Type 2 Diabetes Market by 2020, even though they are not even available in the US at this time.